Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, and a notice regarding delays in study record information has been deleted.SummaryDifference1.0%
- Check13 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.9%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check35 days agoNo Change Detected
- Check49 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website has removed the 'Last Update Posted (Estimated)' and now features a definitive 'Last Update Posted' section.SummaryDifference0.0%
- Check67 days agoChange DetectedRecent updates include new entries for July 2024, while previous updates from February 2024 have been removed.SummaryDifference0.5%
Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.